You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NBIX Sale Disclosure
Sherwin Stephen A · SEC Form 4 · Filed Jun 9, 2026
Sale
Calculated transaction value
$419.16K
Sherwin Stephen A Director
NBIX
Transaction date
Jun 5, 2026
Public filing date
Jun 9, 2026
Filing lag
Filed 4 days later
NBIX daily price context
Close on/before transaction
$163.88
Jun 5, 2026
First close after public filing
$160.86
Jun 10, 2026
30-day return after filing
+12.24%
Through Jul 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,549 shares @ $164.44
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001079462-26-000006
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$5.74M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 5, 2026 | $804.6K |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 5, 2026 | $797.9K |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 5, 2026 | $1.29M |
| Neurocrine Biosciences Inc NBIX Current | Sale | Jun 5, 2026 | $419.16K |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 5, 2026 | $1.14M |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 5, 2026 | $970.86K |
| Neurocrine Biosciences Inc NBIX | Sale | Jun 5, 2026 | $308.36K |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 5, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Exercise | Jun 5, 2026 | $0 |